Randomisation & Sample Size – Clinical BA Study [Power / Sample Size]

posted by Mike_270 – Australia, 2011-02-02 01:47 (5628 d 06:54 ago) – Posting: # 6533
Views: 8,281

Hi ElMaestro,

❝ In the absence of a model

❝ for it I guess you need to either conduct a pilot trial to get an idea

❝ about the effect size in your pivotal trial or press the 'I feel

❝ lucky'-button.


Thankyou for the advice. In terms of randomisation, did you have any comment about using the Williams design 4 treatment sequence design vs. a single treatment sequence (eg. ABCD)? Is it always better to randomise the treatment sequences even with small patient numbers?

Thanks again,

Michael

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
306 visitors (0 registered, 306 guests [including 19 identified bots]).
Forum time: 09:41 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5